GGrantIndex
Sort

16,179 grants matching malaria

Targeting malarial dihydroorotate dehydrogenase

$491,205
University Of Texas Sw Med Ctr/Dallas · R21 · FY2003 · AI

Determining Mechanisms of Cerebral Blood Flow and Metabolism Derangements in Pediatric Cerebral Malaria (FLOW)

$490,977
Nicole Obrien · Research Inst Nationwide Children'S Hosp · R56 · FY2024 · NS

Vector-Borne Diseases: Molecular Mechanisms in Vector-Host Interactions

$490,917
Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Exploiting cross-reactive, conserved epitopes in Plasmodium vivax to develop a vaccine against falciparum placental malaria.

$490,848
Stephanie Yanow · University Of Alberta · R01 · FY2020 · AI

Purine Pathways and Inhibitor Design in Plasmodium

$490,845
Vern L. Schramm · Albert Einstein College Of Medicine · R01 · FY2010 · AI

The Floral Dimension of African Malaria

$490,745
Woodbridge A. Foster · Ohio State University · R01 · FY2010 · AI

Empowering functional genomics of An. gambiae through inversion genotyping

$490,582
Nora J Besansky · University Of Notre Dame · R01 · FY2021 · AI

Use of Electronic Protocols to improve provider and client adherence

$490,516
Marc D. Mitchell · Harvard School Of Public Health · RC1 · FY2009 · TW

Development of Small Molecules as Antiprotozoal Agents

$490,480
Shuren Zhu · Radix Pharmaceuticals, Inc. · R44 · FY2012 · AI

Novel serologic assays of P. falciparum exposure for improved surveillance in control and elimination.

$490,471
Bryan R Greenhouse · University Of California, San Francisco · R01 · FY2020 · AI

University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)

$490,470
Ann R Falsey · University Of Rochester · UM1 · FY2022 · AI

The Function of Antimalarial Drug Resistance Proteins

$490,389
Paul D. Roepe · Georgetown University · R01 · FY2024 · AI

PAPUA NEW GUINEAN DUFFY NEGATIVITY AND VIVAX MALARIA

$490,197
Case Western Reserve University · R01 · FY2005 · AI

Malaria Topoisomerase inhibitors

$490,036
Pradipsinh K. Rathod · University Of Washington · R01 · FY2018 · AI

Malaria Topoisomerase inhibitors

$490,036
Pradipsinh K. Rathod · University Of Washington · R01 · FY2019 · AI

Malaria Topoisomerase inhibitors

$490,036
Pradipsinh K. Rathod · University Of Washington · R01 · FY2020 · AI

Nitric Oxide and Severe Malaria

$490,014
Duke University · R21 · FY2002 · AI

Innate immune responses to malaria liver stage infection

$490,000
Stefan H.i. Kappe · Seattle Biomedical Research Institute · R01 · FY2018 · AI

Infectious Disease/Basic Microbial Pathogenic Mechanisms

$489,947
Daniel E Goldberg · Washington University · T32 · FY2008 · AI

Pregnancy Malaria: Pathogenesis and Immunity

$489,767
Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Influence of temperature on malaria transmission and prospective vector control

$489,575
Matthew B Thomas · Pennsylvania State University, The · R01 · FY2017 · AI

Anti-larval measures for malaria control in The Gambia

$489,487
University Of Durham · U01 · FY2005 · AI

QTRAP 5500 Triple Quadrupole Mass Spectrometer System

$489,330
Ruth Hogue Angeletti · Albert Einstein College Of Medicine · S10 · FY2010 · RR

Environmental determinants of KSHV transmission in rural Uganda

$489,225
Rosemary Rochford · University Of Colorado Denver · R01 · FY2019 · CA

Impact of Mass Drug Administration with or Without Insecticide Impregnated Nets

$489,072
James Walter Kazura · Case Western Reserve University · U19 · FY2009 · AI